Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rickert

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Frontiers in Genetics|December 24, 2015
Transfection of microRNA Mimics Should Be Used with CautionHyun Yong Jin, Alicia Gonzalez-Martin, Ana V Miletic, et al.
The EMBO Journal|October 8, 2004
Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimersGiuseppina Bonizzi, Magali Bebien, Dennis C Otero, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 2012
IL-7 functionally segregates the pro-B cell stage by regulating transcription of recombination mediators across cell cycleKristen Johnson, Julie Chaumeil, Mariann Micsinai, et al.
Cell Reports|December 16, 2014
A pathway switch directs BAFF signaling to distinct NFκB transcription factors in maturing and proliferating B cellsJonathan V Almaden, Rachel Tsui, Yi C Liu, et al.
The Journal of Experimental Medicine|October 20, 2010
Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatasesAna V Miletic, Amy N Anzelon-Mills, David M Mills, et al.
The Journal of Experimental Medicine|April 6, 2021
Regnase-1 is essential for B cell homeostasis to prevent immunopathologyNumana Bhat, Richard Virgen-Slane, Parham Ramezani-Rad, et al.
Immunity|October 16, 2004
Act1, a negative regulator in CD40- and BAFF-mediated B cell survivalYoucun Qian, Jinzhong Qin, Grace Cui, et al.
Journal of Nanoscience and Nanotechnology|June 25, 2008
Cell-type specific and cytoplasmic targeting of PEGylated carbon nanotube-based nanoassembliesMatthew H Cato, Federica D'Annibale, David M Mills, et al.
Nature Immunology|January 24, 2017
Gsk3 is a metabolic checkpoint regulator in B cellsJulia Jellusova, Matthew H Cato, John R Apgar, et al.
Science Advances|August 29, 2025
IgM and IgG1 B cell receptors differentially affect B cell fates and dictate the pathogenesis of mature B cell lymphomasRebecca M Southern, Rebecca L Schmitz, Daniela Samaniego-Castruita, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Frontiers in Genetics|December 24, 2015
Transfection of microRNA Mimics Should Be Used with CautionHyun Yong Jin, Alicia Gonzalez-Martin, Ana V Miletic, et al.
The EMBO Journal|October 8, 2004
Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimersGiuseppina Bonizzi, Magali Bebien, Dennis C Otero, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 2012
IL-7 functionally segregates the pro-B cell stage by regulating transcription of recombination mediators across cell cycleKristen Johnson, Julie Chaumeil, Mariann Micsinai, et al.
Cell Reports|December 16, 2014
A pathway switch directs BAFF signaling to distinct NFκB transcription factors in maturing and proliferating B cellsJonathan V Almaden, Rachel Tsui, Yi C Liu, et al.
The Journal of Experimental Medicine|October 20, 2010
Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatasesAna V Miletic, Amy N Anzelon-Mills, David M Mills, et al.
The Journal of Experimental Medicine|April 6, 2021
Regnase-1 is essential for B cell homeostasis to prevent immunopathologyNumana Bhat, Richard Virgen-Slane, Parham Ramezani-Rad, et al.
Immunity|October 16, 2004
Act1, a negative regulator in CD40- and BAFF-mediated B cell survivalYoucun Qian, Jinzhong Qin, Grace Cui, et al.
Journal of Nanoscience and Nanotechnology|June 25, 2008
Cell-type specific and cytoplasmic targeting of PEGylated carbon nanotube-based nanoassembliesMatthew H Cato, Federica D'Annibale, David M Mills, et al.
Nature Immunology|January 24, 2017
Gsk3 is a metabolic checkpoint regulator in B cellsJulia Jellusova, Matthew H Cato, John R Apgar, et al.
Science Advances|August 29, 2025
IgM and IgG1 B cell receptors differentially affect B cell fates and dictate the pathogenesis of mature B cell lymphomasRebecca M Southern, Rebecca L Schmitz, Daniela Samaniego-Castruita, et al.
Pageof 9